Tengion Secures $1,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=81583018-52c7-4d92-9dc2-2cb9a1e5d56a - Date
9/24/2012 - Company Name
Tengion - Mailing Address
3929 Westpoint Blvd Winston-Salem, NC 27103 USA - Company Description
Tengion (NASDAQ: TNGN) is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient’s own (autologous) cells. Tengion’s proprietary approach to regenerative medicine has the potential to enable people with organ and tissue failure to lead healthier lives without donor transplants or the side effects of current therapies. - Website
http://www.tengion.com - Transaction Type
Debt - Transaction Amount
$1,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
